Skip to content

The Effectiveness of Prophylactic Antibiotics for Urethral Bulking

The Effectiveness of Prophylactic Antibiotics for Urethral Bulking

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06261736
Enrollment
70
Registered
2024-02-15
Start date
2023-10-24
Completion date
2026-01-31
Last updated
2025-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Urinary Incontinence, Postoperative Urinary Tract Infection, Urethral Bulking

Brief summary

The goal of this clinical trial is to evaluate if prophylactic antibiotics in urethral bulking are effective in reducing postprocedural urinary tract infections.

Detailed description

Urethral bulking is a minimally invasive surgical treatment option for stress urinary incontinence (SUI). One commonly reported post-procedural complication is urinary tract infection (UTI). UTI rates are variable where studies have reported rates from as low as 0% to as high as 40%. Along with this variability, the instructional inserts for various bulking agents have inconsistent recommendations for use of prophylactic antibiotics. The American Urologic Association recommends antimicrobial prophylaxis for cystourethroscopy procedures involving minor manipulation. Currently, there are no clear guidelines regarding the utility of prophylactic antibiotics for urethral bulking. The objective of our study is to determine the effectiveness of prophylactic antibiotics in urethral bulking for reducing post procedural UTIs.

Interventions

These participants will be given a single dose of an oral antibiotic prior to the procedure.

These participants will not be given an antibiotic prior to the procedure.

Sponsors

Atlantic Health System
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients scheduled to undergo a urethral bulking procedure * Age 18 ≥ over

Exclusion criteria

* History of recurrent urinary tract infections * Known history of urinary retention * Allergies or contraindications to multiple antibiotics * Inability to tolerate oral antibiotics * Concomitant surgical procedures at the time of urethral bulking * Pregnant or breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Rate of urinary tract infection (UTI)Within 4 weeks after the procedureThe rate of UTI based on symptoms and a positive urine culture

Secondary

MeasureTime frameDescription
Rate of postoperative urinary retentionWithin 4 weeks after the procedureThe rate of postoperative urinary retention
Rates of other postoperative complicationsWithin 4 weeks after the procedureThe rate of other complications (bleeding, discomfort, etc)

Countries

United States

Contacts

Primary ContactTess Gao, MD
tess.gao@atlantichealth.org973-971-7267

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026